CDER Director Janet Woodcock on new drug safety strategies

November 16, 2010- by Steven E. Greer, MD

We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible for approving drugs and monitoring for safety.

In Part 1, she reviews her responsibilities as Director over a period of time spanning both Republican and Democratic administrations. The recent ACA healthcare reform law and the 2007 FDAAA have radically changed how the FDA is handling safety of drugs.

This entry was posted in - Pharma, FDA. Bookmark the permalink.

Leave a Reply

Your email address will not be published.